...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Reports of Exempt Distribution

These financings seem to be getting cheaper and cheaper.

Wasn't it $1.50 a while ago, and $2 before that?

Going in the wrong direction...

Share
New Message
Please login to post a reply